Martijn W C Verbeek

5PUBLICATIONS
6CO-AUTHORS
Sequence analysisMedical bacteriologyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 19, 2026
The impact of scaRNA12 deregulation on p53-mediated cellular stress response in B-cell precursor acute lymphoblastic leukaemia.

Martijn W C Verbeek, Mathijs A Sanders, Dwin G B Grashof

|Apr 14, 2025
Minimal residual disease assessment following CD19-targeted therapy in B-cell precursor acute lymphoblastic leukemia using standardized 12-color flow cytometry: A EuroFlow study.

Martijn W C Verbeek, Michaela Reiterová, Anna Laqua

|May 11, 2024
The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia.

Martijn W C Verbeek, Vincent H J van der Velden

|Jun 24, 2022
Dysregulation of Small Nucleolar RNAs in B-Cell Malignancies.

Martijn W C Verbeek, Stefan J Erkeland, Vincent H J van der Velden

|Dec 09, 2021
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study.

Martijn W C Verbeek, Chiara Buracchi, Anna Laqua

Pageof 1

Frequent Collaborators

4 joint publications

Vincent H J van der Velden

2 joint publications

Stefan J Erkeland

1 joint publications

Ester Mejstrikova

1 joint publications

Tomasz Szczepanski